SV Health Investors

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
3
Rounds led
0
Rounds' value
$55.3M
total disclosed, rounds participated
Stages
—

Portfolio · 2

Prilenia Therapeutics
Developing New Treatments for Neurodegenerative Diseases
1 round $11.0M committed Latest: 2022-04
Cadent
3D Digital-imaging Dentistry Solutions
2 rounds $44.3M committed Latest: 2009-08

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is SV Health Investors' primary sector focus?
SV Health Investors primarily focuses on the Health Tech &.
Can you name a notable exit for SV Health Investors?
In March 2011, SV Health Investors saw Cadent, a 3D.
What is one of SV Health Investors' recent portfolio companies?
SV Health Investors has invested in Prilenia Therapeutics, a company founded in 2018 that is developing new treatments for neurodegenerative diseases. Prilenia Therapeutics raised a Series B round of $144.5M.
What is the typical investment range for SV Health Investors?
SV Health Investors typically invests in the range of $11M - $25M.
When was SV Health Investors founded?
SV Health Investors was founded in 2019.